Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1999
10/07/1999WO1999049854A2 Use of dexmedetomidine for icu sedation
10/07/1999WO1999049853A1 Therapeutic system which can be moisture-activated
10/07/1999WO1999049852A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
10/07/1999WO1999049843A1 Solid, quick dissolving cetirizine formulations
10/07/1999WO1999049842A1 Fizzy formulations
10/07/1999WO1999042456A3 Novel compounds and their use as positive ampa receptor modulators
10/07/1999WO1999040220A3 Method of screening therapeutic agents
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/07/1999DE19814701A1 Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von mit dem Gehirn assoziierten Erkrankungen, Störungen und Schädigungen Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and injuries
10/07/1999DE19814257A1 Brauseformulierungen Effervescent formulations
10/07/1999DE19814256A1 Feste, schnellzerfallende Cetirizin-Formulierungen Solid rapidly disintegrating cetirizine formulations
10/07/1999CA2333927A1 Pyrimidines and triazines as integrin antagonists
10/07/1999CA2326576A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999CA2325858A1 Stable dosage forms of fluoxetine and its enantiomers
10/06/1999EP0947584A1 Loxoprofen-containing preparation for external use
10/06/1999EP0947506A1 2-Aza-bicyclo[2.2.1]heptane derivatives and their use as rotamase inhibitors
10/06/1999EP0947193A2 Percutaneously applicable preparation and suppository containing an antidementia medicament
10/06/1999EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999EP0946724A2 POLYPEPTIDES OF THE "BASIC-HELIX-LOOP-HELIX" bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946596A1 Peptide derivatives
10/06/1999EP0946595A2 Melanocortins
10/06/1999EP0946588A1 Use of dipeptide derivatives
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946564A1 New process for the preparation of morphinans
10/06/1999EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999EP0946561A1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
10/06/1999EP0946551A2 N-piperazin-1-ylphenyl-benzamide derivatives
10/06/1999EP0946546A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
10/06/1999EP0946542A1 Indane or dihydroindole derivatives
10/06/1999EP0946541A1 Quinolines and their therapeutic use
10/06/1999EP0946539A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
10/06/1999EP0946538A1 Indane or dihydroindole derivatives
10/06/1999EP0946520A1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946511A1 Novel compounds with analgesic effect
10/06/1999EP0946510A1 Novel compounds with analgesic effect
10/06/1999EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
10/06/1999EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
10/06/1999EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999EP0946499A1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0946190A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
10/06/1999EP0946182A1 17$g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
10/06/1999EP0946181A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
10/06/1999EP0946179A1 Method for treating autism
10/06/1999EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy
10/06/1999EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999EP0946162A1 Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
10/06/1999EP0946157A2 The topical use of kappa opioid agonists to treat ocular pain
10/06/1999EP0946096A1 Nefazodone: use in treating post traumatic stress disorder
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999CN1230962A 3-substituted pyrido [4',3' : 4, 5] thieno [2,3-D] pyrimidine derivatives, their preparation and their use
10/06/1999CN1230959A N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
10/06/1999CN1230948A Pyranoindole and carbazole inhibitors of COX-2
10/06/1999CN1230894A Pharmaceutical composition containing a 5HT2C antagonist and A D2 antagonist
10/06/1999CN1230889A Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
10/06/1999CN1230886A Combination therapy for treatment of psychoses
10/06/1999CN1230885A Use of benzopyranols to treat neurological disorders
10/06/1999CN1230883A Coated particle formulation
10/05/1999US5962682 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
10/05/1999US5962532 Therapeutic method with capsaicin and capsaicin analogues
10/05/1999US5962521 Prostate glands disorders
10/05/1999US5962514 Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist
10/05/1999US5962496 Central nervous system disorders
10/05/1999US5962486 Headache therapy
10/05/1999US5962485 N-(2-benzyloxy-1-phenethyl)-N-(2'-methoxyethyl)amino-methane compounds are useful as tachykinin antagonists
10/05/1999US5962480 Containing pyran-4-one or pyrid-4-one ring
10/05/1999US5962479 Psychological and nervous sytem disorders
10/05/1999US5962474 Analgesics; headaches
10/05/1999US5962472 Alzheimer's, parkinson, huntington diseases; amyotropic laterial sclerosis; nervous system disorders
10/05/1999US5962465 Brain disorders; psychological disorders
10/05/1999US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
10/05/1999US5962451 Gastrointestinal disorders; antiulcer agent; anticancer agents; side-effect reduction
10/05/1999US5962450 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
10/05/1999US5962449 Analgesics; antiinflammatory agents; non-insulin-dependentdiabetes
10/05/1999US5962447 Psychological disorders, cognition activators, schizophrenia
10/05/1999US5962446 Administering protein kinase inhibitors
10/05/1999US5962419 Nervous system disorders; brain disorders
10/05/1999US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system.
10/05/1999US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
10/05/1999CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists
10/05/1999CA2175204C Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
10/01/1999CA2249043A1 Novel compounds
09/1999
09/30/1999WO1999049039A2 GFRα3 AND ITS USES
09/30/1999WO1999049038A2 Human calcium-binding proteins
09/30/1999WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999WO1999048892A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors
09/30/1999WO1999048891A1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
09/30/1999WO1999048881A1 Metalloproteinase inhibitors
09/30/1999WO1999048858A2 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999WO1999048522A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
09/30/1999WO1999048507A2 Steroidal saponins for treating alzheimer's disease
09/30/1999WO1999048500A1 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
09/30/1999WO1999048499A1 Paroxetine compositions
09/30/1999WO1999048488A2 Methods for decreasing beta amyloid protein
09/30/1999WO1999048485A1 Method of treating neuroma pain
09/30/1999WO1999048484A2 Use of cabergoline in the treatment of restless legs syndrome
09/30/1999WO1999048482A2 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
1 ... 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 ... 1833